Matches in SemOpenAlex for { <https://semopenalex.org/work/W2409857097> ?p ?o ?g. }
Showing items 1 to 71 of
71
with 100 items per page.
- W2409857097 endingPage "401" @default.
- W2409857097 startingPage "398" @default.
- W2409857097 abstract "The aim was to follow-up gonadal functions in long-term survivors of acute myeloid leukemias (AML) after intensive chemotherapy based on high-doses of cytosine arabinoside (Ara-C) and anthracyclines in the study UHKT-911.Adult patients were treated with at least 3 cycles of chemotherapy including 1-3 courses of Ara-C 10x2000 mg/m 2 /12 h and daunorubicin (DNR) 2x45 mg/m 2 /d. Spermiologic examinations were performed in 7 men by the classic microscopic method and results were evaluated according to the WHO criteria. Two patients (42- and 47-year-old) after DNR and Ara-C chemotherapy had nearly normal spermiologic findings. The semen of a 49-year-old patient contained normal numbers of spermatozoa with decreased velocity when examined 1 year after chemotherapy but 4 years later exhibited oligoasthenozoospermia. The patient received 4 cycles of Ara-C and DNR plus one cycle with etoposide 350 mg/m 2 and mitoxantrone 30 mg/m 2 . Semen examination of two patients 55- and 59-year-old showed permanent oligoasthenozoospermia with only sporadic progressively motile spermatozoa which might not be compatible with fertilization by sexual intercourse. They received the same chemotherapy including cumulative doses of etoposide 500 mg/m 2 and mitoxantrone 36 mg/m 2 . Semen of two patients after allogeneic bone marrow transplantation exhibited severe oligoasthenozoospermia with no motile spermatozoa. Permanent amenorrhea developed in two women (42- and 46-year-old) during chemotherapy with DNR, Ara-C, etoposide, and mitoxantrone which was not the case in three women (29-40 years old) treated without etoposide and mitoxantrone. Intensive chemotherapy with high-doses of Ara-C and DNR plus one cycle of etoposide and mitoxantrone may cause permanent gonadal dysfunction in middle-aged patients with AML." @default.
- W2409857097 created "2016-06-24" @default.
- W2409857097 creator A5036376214 @default.
- W2409857097 creator A5051303456 @default.
- W2409857097 date "2005-01-01" @default.
- W2409857097 modified "2023-09-24" @default.
- W2409857097 title "Chemotherapy for acute myeloid leukemias with cytosine arabinoside, daunorubicin, etoposide, and mitoxantrone may cause permanent oligoasthenozoospermia or amenorrhea in middle-aged patients." @default.
- W2409857097 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16151584" @default.
- W2409857097 hasPublicationYear "2005" @default.
- W2409857097 type Work @default.
- W2409857097 sameAs 2409857097 @default.
- W2409857097 citedByCount "2" @default.
- W2409857097 countsByYear W24098570972014 @default.
- W2409857097 countsByYear W24098570972019 @default.
- W2409857097 crossrefType "journal-article" @default.
- W2409857097 hasAuthorship W2409857097A5036376214 @default.
- W2409857097 hasAuthorship W2409857097A5051303456 @default.
- W2409857097 hasConcept C126322002 @default.
- W2409857097 hasConcept C143998085 @default.
- W2409857097 hasConcept C2776694085 @default.
- W2409857097 hasConcept C2778041864 @default.
- W2409857097 hasConcept C2778119113 @default.
- W2409857097 hasConcept C2780847677 @default.
- W2409857097 hasConcept C2780923524 @default.
- W2409857097 hasConcept C2781021840 @default.
- W2409857097 hasConcept C71924100 @default.
- W2409857097 hasConcept C90924648 @default.
- W2409857097 hasConcept C98274493 @default.
- W2409857097 hasConceptScore W2409857097C126322002 @default.
- W2409857097 hasConceptScore W2409857097C143998085 @default.
- W2409857097 hasConceptScore W2409857097C2776694085 @default.
- W2409857097 hasConceptScore W2409857097C2778041864 @default.
- W2409857097 hasConceptScore W2409857097C2778119113 @default.
- W2409857097 hasConceptScore W2409857097C2780847677 @default.
- W2409857097 hasConceptScore W2409857097C2780923524 @default.
- W2409857097 hasConceptScore W2409857097C2781021840 @default.
- W2409857097 hasConceptScore W2409857097C71924100 @default.
- W2409857097 hasConceptScore W2409857097C90924648 @default.
- W2409857097 hasConceptScore W2409857097C98274493 @default.
- W2409857097 hasIssue "5" @default.
- W2409857097 hasLocation W24098570971 @default.
- W2409857097 hasLocation W24098570972 @default.
- W2409857097 hasOpenAccess W2409857097 @default.
- W2409857097 hasPrimaryLocation W24098570971 @default.
- W2409857097 hasRelatedWork W107183160 @default.
- W2409857097 hasRelatedWork W1755058843 @default.
- W2409857097 hasRelatedWork W1968201909 @default.
- W2409857097 hasRelatedWork W1978668887 @default.
- W2409857097 hasRelatedWork W1986401524 @default.
- W2409857097 hasRelatedWork W2030471987 @default.
- W2409857097 hasRelatedWork W2034822277 @default.
- W2409857097 hasRelatedWork W2046873907 @default.
- W2409857097 hasRelatedWork W2055753713 @default.
- W2409857097 hasRelatedWork W2078077818 @default.
- W2409857097 hasRelatedWork W2383882644 @default.
- W2409857097 hasRelatedWork W2406605612 @default.
- W2409857097 hasRelatedWork W2411066563 @default.
- W2409857097 hasRelatedWork W2412195769 @default.
- W2409857097 hasRelatedWork W2414743797 @default.
- W2409857097 hasRelatedWork W2426428492 @default.
- W2409857097 hasRelatedWork W2428176757 @default.
- W2409857097 hasRelatedWork W2465909505 @default.
- W2409857097 hasRelatedWork W2466479474 @default.
- W2409857097 hasRelatedWork W33382804 @default.
- W2409857097 hasVolume "52" @default.
- W2409857097 isParatext "false" @default.
- W2409857097 isRetracted "false" @default.
- W2409857097 magId "2409857097" @default.
- W2409857097 workType "article" @default.